stella
beta
Treatment of Relapsed or Refractory Epstein-Barr Virus Positive T-cell Lymphoma With hNeo-T — Stella
Recruiting
Back to T-cell Lymphoma trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
ShenZhen University General Hospital, Shenzhen, Guangdong
View full record on ClinicalTrials.gov